USD 0.02
(2.44%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.53 Million USD | 19.76% |
2022 | 5.08 Million USD | 1.28% |
2021 | 5.01 Million USD | 34.79% |
2020 | 3.72 Million USD | 14.19% |
2019 | 3.26 Million USD | 21.18% |
2018 | 2.69 Million USD | 65.69% |
2017 | 1.62 Million USD | 25.44% |
2016 | 1.29 Million USD | 139.07% |
2015 | 541.56 Thousand USD | 266.46% |
2014 | -325.34 Thousand USD | 20.39% |
2013 | -408.65 Thousand USD | 67.97% |
2012 | -1.27 Million USD | -302.35% |
2011 | 630.45 Thousand USD | 219.43% |
2010 | 197.36 Thousand USD | 126.63% |
2009 | 87.08 Thousand USD | 158.06% |
2008 | -150 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 1.23 Million USD | 35.4% |
2024 Q2 | 1.22 Million USD | 4.11% |
2023 Q4 | 915.46 Thousand USD | -48.64% |
2023 Q2 | 2.72 Million USD | 160.37% |
2023 Q1 | 1.04 Million USD | -19.92% |
2023 Q3 | 1.78 Million USD | -34.51% |
2023 FY | 6.08 Million USD | 19.76% |
2022 Q1 | 1.46 Million USD | 64.49% |
2022 FY | 5.08 Million USD | 1.28% |
2022 Q4 | 1.3 Million USD | 6.38% |
2022 Q3 | 1.22 Million USD | 12.86% |
2022 Q2 | 1.08 Million USD | -25.73% |
2021 Q4 | 889.97 Thousand USD | -46.27% |
2021 FY | 5.01 Million USD | 34.79% |
2021 Q3 | 1.65 Million USD | 89.65% |
2021 Q1 | 1.59 Million USD | 54.96% |
2021 Q2 | 873.45 Thousand USD | -45.39% |
2020 Q3 | 774.47 Thousand USD | -19.0% |
2020 FY | 3.72 Million USD | 14.19% |
2020 Q1 | 989.95 Thousand USD | 31.92% |
2020 Q4 | 1.03 Million USD | 33.28% |
2020 Q2 | 956.14 Thousand USD | -3.42% |
2019 Q1 | 757.46 Thousand USD | 3.63% |
2019 FY | 3.26 Million USD | 21.18% |
2019 Q2 | 839.47 Thousand USD | 10.83% |
2019 Q3 | 913.61 Thousand USD | 8.83% |
2019 Q4 | 750.43 Thousand USD | -17.86% |
2018 FY | 2.69 Million USD | 65.69% |
2018 Q1 | 597.29 Thousand USD | 31.14% |
2018 Q4 | 730.95 Thousand USD | 1.38% |
2018 Q3 | 720.99 Thousand USD | 12.35% |
2018 Q2 | 641.71 Thousand USD | 7.44% |
2017 Q4 | 455.44 Thousand USD | 31.54% |
2017 FY | 1.62 Million USD | 25.44% |
2017 Q3 | 346.23 Thousand USD | -27.59% |
2017 Q2 | 478.14 Thousand USD | 38.9% |
2017 Q1 | 344.24 Thousand USD | 27.88% |
2016 Q3 | 283.18 Thousand USD | -28.96% |
2016 Q4 | 269.19 Thousand USD | -4.94% |
2016 Q2 | 398.62 Thousand USD | 15.98% |
2016 FY | 1.29 Million USD | 139.07% |
2016 Q1 | 343.68 Thousand USD | 44.84% |
2015 Q2 | -38.58 Thousand USD | -122.63% |
2015 FY | 541.56 Thousand USD | 266.46% |
2015 Q4 | 237.29 Thousand USD | 37.65% |
2015 Q1 | 170.46 Thousand USD | 157.99% |
2015 Q3 | 172.39 Thousand USD | 546.82% |
2014 Q4 | -293.92 Thousand USD | -563.31% |
2014 Q3 | 63.44 Thousand USD | 156.12% |
2014 Q2 | -113.04 Thousand USD | -721.59% |
2014 FY | -325.34 Thousand USD | 20.39% |
2014 Q1 | 18.18 Thousand USD | -4.28% |
2013 Q2 | 1853.00 USD | 100.5% |
2013 Q3 | -55.99 Thousand USD | -3121.59% |
2013 Q4 | 19 Thousand USD | 133.94% |
2013 FY | -408.65 Thousand USD | 67.97% |
2013 Q1 | -373.52 Thousand USD | 45.86% |
2012 Q2 | 442.26 Thousand USD | 14.18% |
2012 Q1 | 387.35 Thousand USD | 59.53% |
2012 Q4 | -689.89 Thousand USD | -1212.97% |
2012 FY | -1.27 Million USD | -302.35% |
2012 Q3 | 61.98 Thousand USD | -85.98% |
2011 FY | 630.45 Thousand USD | 219.43% |
2011 Q1 | 109.07 Thousand USD | 13682.94% |
2011 Q2 | 80.71 Thousand USD | -26.0% |
2011 Q3 | 197.86 Thousand USD | 145.14% |
2011 Q4 | 242.8 Thousand USD | 22.71% |
2010 FY | 197.36 Thousand USD | 126.63% |
2010 Q2 | 66.85 Thousand USD | 58.46% |
2010 Q4 | -803.00 USD | -100.9% |
2010 Q3 | 89.12 Thousand USD | 33.31% |
2010 Q1 | 42.19 Thousand USD | 7.52% |
2009 Q4 | 39.24 Thousand USD | 55.39% |
2009 Q3 | 25.25 Thousand USD | 0.0% |
2009 FY | 87.08 Thousand USD | 158.06% |
2008 FY | -150 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Achiko AG | 23.34 Thousand USD | -27876.042% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | 3.91 Million USD | -66.756% |
Cannabis Sativa, Inc. | 773.08 Thousand USD | -744.799% |
CompuMed, Inc. | 2.88 Million USD | -126.285% |
CompuGroup Medical SE & Co. KGaA | 413.14 Million USD | 98.419% |
Cogstate Limited | 24.7 Million USD | 73.564% |
Craneware plc | 162.19 Million USD | 95.973% |
Caduceus Software Systems Corp. | 925.07 Thousand USD | -605.998% |
Certive Solutions Inc. | 137.87 Thousand USD | -4636.973% |
Drug Free Solution, Inc. | 805.00 USD | -811205.217% |
DATATRAK International, Inc. | 5.14 Million USD | -26.879% |
Strainsforpains, Inc. | 84.11 Thousand USD | -7664.286% |
Healixa Inc. | 210.81 Thousand USD | -2998.054% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 12.3 Million USD | 46.915% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | 82.05 Thousand USD | -7859.595% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | -298.05 USD | 2191345.429% |
IQ-AI Limited | 614.03 Thousand USD | -963.621% |
Cannabiz Mobile, Inc. | - USD | -Infinity% |
Mednow Inc. | -858.82 Thousand USD | 860.462% |
Galileo Life Sciences, Inc. | - USD | -Infinity% |
MediXall Group, Inc. | -3.13 Million USD | 308.063% |
Mitesco, Inc. | - USD | -Infinity% |
MobileSmith, Inc. | 821.2 Thousand USD | -695.3% |
NantHealth, Inc. | 38.16 Million USD | 82.887% |
Net Medical Xpress Solutions, Inc. | -60 Thousand USD | 10985.012% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | 222.9 Thousand USD | -2830.017% |
Patient Access Solutions, Inc. | 212.73 Thousand USD | -2970.006% |
Pharma-Bio Serv, Inc. | 5.06 Million USD | -28.908% |
PPJ Healthcare Enterprises, Inc. | 216.06 Thousand USD | -2922.691% |
Medical Cannabis Payment Solutions, Inc. | -21.91 Thousand USD | 29898.818% |
Renalytix Plc | 156 Thousand USD | -4086.543% |
Revium Recovery Inc. | -2000.00 USD | 326650.35% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | 396.65 Thousand USD | -1546.542% |
Vaso Corporation | 50.59 Million USD | 87.091% |
Vynleads, Inc. | -35.57 Thousand USD | 18460.998% |